Jefferies and TD Cowen issued ratings and coverage updates for Honeywell Aerospace on July 1, 2026.
14 reports, 2 independent
Updated Sep 24
Gone quiet
Reached 3 outlets in its first 24 hours
- Reports
- 14
- Developments
- 2
- Repetition
- 86%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Jefferies and TD Cowen issued ratings and coverage updates for Honeywell Aerospace on July 1, 2026.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Jefferies and TD Cowen issued new price targets and coverage for Honeywell Aerospace.1 source
Jefferies set a price objective and rating, while TD Cowen began coverage for Honeywell Aerospace.1 source
Keep exploring
Part of
Multiple financial institutions, including Jefferies, Cantor Fitzgerald, TD Cowen, and RBC, issued various rating updates on July 1, 2026.Also in this story
- Financial firms including Royal Bank of Canada, TD Cowen, and Jefferies Financial Group have issued research reports, ratings, and price targets for Hexcel stock.
- Financial firms, including Jefferies and Cantor Fitzgerald, adjusted price targets and ratings for Molina Healthcare shares.
The entities involved
-
Honeywell Aerospace
company
-
Jefferies Financial Group
American financial services company
- MarketBeat reported consensus rating for Hikma Pharmaceuticals, while Jefferies increased its target price and gave a buy rating. Berenberg Bank reaffirmed its buy rating, and Citigroup restated a buy rating.
- Financial firms, including Jefferies, Morgan Stanley, and Cantor Fitzgerald, issued rating updates and lowered earnings estimates for Arcutis Biotherapeutics.
-
TD Cowen
American investment bank
Related events
- TD Cowen decreased its target price and set a hold rating for Honeywell Aerospace, with MarketBeat reporting the average stock rating.
- Analyst firms Jefferies, TD Cowen, and Raymond James Financial provided rating updates for Black Diamond Therapeutics, alongside MarketBeat consensus data.
- Texas Roadhouse received multiple analyst rating and price target updates from Jefferies and TD Cowen, alongside stock listing information.